SightfileU.S. market data from official filings

Companies › RNAZ

TransCode Therapeutics Inc (RNAZ)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001829635 · EDGAR filings · Updated 2026-07-28

TransCode Therapeutics Inc (RNAZ) has reported institutional ownership of 3.4%, with 8 institutional managers holding positions valued at $265.7K per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
3.4%
Institutional managers
8
Reported 13F value
$265.7K
Data flags
2 active
from SEC filings

Filings this week (5)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, TransCode Therapeutics Inc has 8 institutional holders and institutional ownership of 3.4%.

Insider activity

Insiders reported 0 transactions (0 buys, 0 sells) across 0 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2026-05-26 (recurring since 2022-12-09) — source filing. The authoritative details are those stated in the filing itself.
Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-15 (recurring since 2021-11-15) — source filing. The authoritative details are those stated in the filing itself.

Related companies

FIBROBIOLOGICS INC (FBLG) · NEUROSENSE THERAPEUTICS LTD (NRSN) · Tenon Medical Inc (TNON) · ENSYSCE BIOSCIENCES INC (ENSC) · LIMINATUS PHARMA INC. (LIMN) · CYCLERION THERAPEUTICS INC COM (CYCN)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-28.